Assessing the Impact of eSight Go At-Home Usage in Individuals With Visual Impairment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorBrooks Rehabilitation

About this trial

This research aims to test the updated version of Gentex's device, eSight Go, an image enhancing wearable device to assist those with vision impairments limiting activities of daily living.

Eligibility criteria

Qualifiers

Aged 18 to 90.

Best-corrected visual acuity between 20/50 to 20/400 in the better eye.

Subjects who have been diagnosed with an ocular condition causing visual impairment

Have a functional binocular field of view of at least 20 degrees.

Disqualifiers

Participant must not be currently undergoing any medical or surgical procedures resulting in unstable vision.

Participants who have undergone cataract, refractive, or other surgical procedures related to vision in the six-month period prior to study enrollment.

Severe (>20/400) visual impairment in the better seeing eye.

Cognitive limitations (< 20 on OMCT).

Trial design

Treatments tested in this trial

  • At Home Use

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators